Clinical Trials Logo

Stillbirth clinical trials

View clinical trials related to Stillbirth.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03909737 Active, not recruiting - Clinical trials for Stillbirths and Infant Mortality

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

SANTE
Start date: September 24, 2020
Phase: Phase 4
Study type: Interventional

The double blind randomized controlled trial will assess the efficacy of oral azithromycin administered to pregnant women and/or infants during routine care in preventing stillbirths and mortality through 6-12 months of age in Mali, West Africa, where rates of infant and under five mortality are among the highest in the world.

NCT ID: NCT01995968 Active, not recruiting - Clinical trials for Infant, Small for Gestational Age

Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.

REPERE
Start date: November 2013
Phase: N/A
Study type: Observational [Patient Registry]

The main objective is to assess the role of antenatal detection of fetal growth restriction (FGR) on stillbirth, by a case-control study in a population-based sample of small for gestational age (SGA) livebirths and stillbirths in 3 French counties (Isère, Savoie and Haute-Savoie). SGA births will be defined as a birthweight below the 10th percentile of French customised birth weight curves. Our secondary objectives are - to identify determinants of antenatal detection of FGR among a representative sample of SGA births, with a special interest in the definition of FGR. Our hypothesis is that births who are SGA by customised birthweight curves and non-SGA by population birthweight curves, are not detected antenatally, despite the current strategy including the use of umbilical Doppler. - to analyse prenatal care of a subsample of SGA stillbirths with and without detection of FGR by a confidential enquiry.